LabCompass

Brendan K. Ball

Medicine · Purdue University West Lafayette

OpenAlex ORCID
Established · publishing since 1996Rising activity
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsTryptophan and brain disordersOsteoarthritis Treatment and MechanismsHIV Research and Treatment

Publications

21

Citations

105

Est. group size

~2

Recurring co-author estimate

Active years

31

Publishing since 1996

Research summary
AI-generated

Brendan K. Ball works on computational and translational approaches that connect findings from animal models (mice, sheep) to human disease, especially links between type 2 diabetes, Alzheimer's disease, and osteoarthritis. This work involves analyzing molecular data such as gene expression, metabolites, and immune signaling to identify biomarkers and potential drug targets that carry over from lab animals to people.

Cross-species and translational disease modelingAlzheimer's disease and neurodegenerationType 2 diabetes and metabolic disease links to brain disordersComputational biology and bioinformaticsOsteoarthritis and musculoskeletal disease modeling

Publication output was minimal or absent in the earlier part of the decade but has grown markedly since 2023, with a notable increase in output in 2024-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.8/year recently
1718192020: 1 publication202021: 1 publication21222023: 1 publication232024: 4 publications242025: 7 publications7252026: 2 publications26
Recent publications
Publishes in
  • bioRxiv (Cold Spring Harbor Laboratory)×7
  • ACS Nano×1
  • Scientific Reports×1
  • npj Systems Biology and Applications×1
  • Osteoarthritis and Cartilage×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile